1. Market Research
  2. > Pathology Industry

Pancreatic Cancer Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Antigen, Therapeutics, Cancer Diagnostic, Diagnostics, Therapy.


 
1-10 of 40 reports for Pancreatic Cancer

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

  • $ 6 172
  • Industry report
  • February 2016
  • by Black Swan Analysis Ltd

Summary Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result ...

Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, U.S., Germany, France, U.K., Italy, Spain, Japan

Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, U.S., Germany, France, U.K., Italy, Spain, Japan

  • $ 4 650
  • Industry report
  • May 2016
  • by MarketsandMarkets

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 million by 2021, at a CAGR of 13.9% from 2016 to 2021. The growing incidence of pancreatic cancer (especially pNET) and ...

Global Pancreatic Cancer Partnering 2010 to 2016

Global Pancreatic Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Metastatic Pancreatic Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic ...

Pancreatic Cancer -Pipeline Insights, 2016

Pancreatic Cancer -Pipeline Insights, 2016

  • $ 2 250
  • Industry report
  • February 2016
  • by Delve Insight

Summary DelveInsight’s, “Pancreatic Cancer -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

Target Atlas in Pancreatic Cancer: A Competitive Outlook

Target Atlas in Pancreatic Cancer: A Competitive Outlook

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Pancreatic Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in ...

Pancreatic Cancer Drug Pipeline Update

Pancreatic Cancer Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

There are today 367 companies plus partners developing 406 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ...

Pancreatic Cancer Drug Pathway Analyzer

Pancreatic Cancer Drug Pathway Analyzer

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 382 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways ...

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

About 1 800 reports for Pancreatic Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • June 2015
    110 pages
  • Pancreatic Canc...  

    Cancer  

  • United States  

View report >

Cancer Drug Industry

January 2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.